Please enable JavaScript to continue using this application.

Compare $SABS vs $ZSQR | Chartloom

Compare

$SABS vs $ZSQR

SAB Biotherapeutics Inc · Z Squared Inc (Delaware)

SABS

SAB Biotherapeutics Inc

ZSQR

Z Squared Inc (Delaware)

Compare $SABS vs $ZSQR

Comparing SAB Biotherapeutics Inc and Z Squared Inc (Delaware)

SABSSAB Biotherapeutics Inc

ZSQRZ Squared Inc (Delaware)

SABSSAB Biotherapeutics Inc

Market cap

$228M

P/E (TTM)

20.43x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-21.0%

52W performance

27.4%

FCF yield

-25.2%

ZSQRZ Squared Inc (Delaware)

Market cap

$298M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

961.0%

YTD performance

-62.8%

52W performance

-62.8%

FCF yield

-1.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

SABS

ZSQR

Detailed metrics comparison

SABS

SAB Biotherapeutics Inc

ZSQR

Z Squared Inc (Delaware)

Market Cap

SABS$228M

ZSQR$298M

Enterprise Value

SABS$223M

ZSQR$283M

Price

SABS$2.98

ZSQR$5.66

P/E Ratio

SABS20.43x

ZSQRN/A

P/S Ratio

SABS204.97x

ZSQR106.71x

EV/Sales

SABS201.14x

ZSQR101.17x

EV/EBITDA

SABS0.00x

ZSQR0.00x

P/B Ratio

SABS1.26x

ZSQR1.36x

P/FCF Ratio

SABSN/A

ZSQRN/A

EV/FCF

SABS-3.88x

ZSQR-69.99x

PEG Ratio

SABSN/A

ZSQRN/A

Forward P/E (NTM)

SABSN/A

ZSQRN/A

Forward P/S (NTM)

SABSN/A

ZSQRN/A

Revenue (TTM)

SABS$0

ZSQR$3M

Revenue Growth (YoY)

SABSN/A

ZSQR961.0%

Forward Rev Growth

SABS13369.8%

ZSQR0.0%

Gross Margin (TTM)

SABS0.0%

ZSQR-24.6%

Operating Margin (TTM)

SABS0.0%

ZSQR0.0%

EBITDA Margin (TTM)

SABS0.0%

ZSQR-712.5%

Net Margin (TTM)

SABS0.0%

ZSQR-785.1%

FCF Margin (TTM)

SABSN/A

ZSQR-144.6%

Net Income (TTM)

SABS$2M

ZSQR$-22M

FCF (TTM)

SABS$-57M

ZSQR$-4M

EPS (TTM)

SABS$0.00

ZSQR-$0.44

ROE (TTM)

SABS15.2%

ZSQR-5059.0%

ROA (TTM)

SABS12.5%

ZSQR-4757.0%

ROIC (TTM)

SABS14.6%

ZSQR-5038.0%

Cash

SABS$8M

ZSQR$15M

Debt

SABS$3M

ZSQR$0

Net Cash/Debt

SABS$5M

ZSQR$15M

Current Ratio (TTM)

SABS9.22x

ZSQR7.66x

Quick Ratio (TTM)

SABS8.93x

ZSQR7.64x

Debt/Equity (TTM)

SABS0.01x

ZSQR0.02x

Debt/Assets (TTM)

SABS0.0%

ZSQR0.0%

Interest Coverage (TTM)

SABSN/A

ZSQRN/A

Net Debt/EBITDA (TTM)

SABS0.00x

ZSQR0.00x

Beta

SABS0.80

ZSQRN/A

52W Performance

SABS27.4%

ZSQR-62.8%

YTD Performance

SABS-21.0%

ZSQR-62.8%

% from 52W High

SABS-42.1%

ZSQR-69.9%

% from 52W Low

SABS41.9%

ZSQR168.2%

Asset Turnover (TTM)

SABS0.02x

ZSQR0.06x

FCF Yield (TTM)

SABS-25.2%

ZSQR-1.4%

Earnings Yield (TTM)

SABS1.1%

ZSQR-7.4%

Dividend Yield (TTM)

SABSN/A

ZSQRN/A

Rule of 40

SABS0.0

ZSQR816.4

EV/GP/RG

SABSN/A

ZSQRN/A

Ticker research

View SABS research View ZSQR research

Metric	SABS SAB Biotherapeutics Inc	ZSQR Z Squared Inc (Delaware)
Market & Valuation
Market Cap	$228M	$298M
Enterprise Value	$223M	$283M
Price	$2.98	$5.66
P/E Ratio	20.43x	N/A
P/S Ratio	204.97x	106.71x
EV/Sales	201.14x	101.17x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.26x	1.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.88x	-69.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	961.0%
Forward Rev Growth	13369.8%	0.0%
Profitability
Gross Margin (TTM)	0.0%	-24.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-712.5%
Net Margin (TTM)	0.0%	-785.1%
FCF Margin (TTM)	N/A	-144.6%
Net Income (TTM)	$2M	$-22M
FCF (TTM)	$-57M	$-4M
EPS (TTM)	$0.00	-$0.44
ROE (TTM)	15.2%	-5059.0%
ROA (TTM)	12.5%	-4757.0%
ROIC (TTM)	14.6%	-5038.0%
Financial Health
Cash	$8M	$15M
Debt	$3M	$0
Net Cash/Debt	$5M	$15M
Current Ratio (TTM)	9.22x	7.66x
Quick Ratio (TTM)	8.93x	7.64x
Debt/Equity (TTM)	0.01x	0.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.80	N/A
52W Performance	27.4%	-62.8%
YTD Performance	-21.0%	-62.8%
% from 52W High	-42.1%	-69.9%
% from 52W Low	41.9%	168.2%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.06x
FCF Yield (TTM)	-25.2%	-1.4%
Earnings Yield (TTM)	1.1%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	816.4
EV/GP/RG	N/A	N/A
Ticker research	View SABS research	View ZSQR research

Valuation

P/E Ratio

SABS

20.43x

P/S Ratio

ZSQR

106.71x

SABS

204.97x

EV/FCF

ZSQR

-69.99x

SABS

-3.88x

Growth & revenue

Revenue Growth TTM

ZSQR

961.0%

Forward Revenue Growth

SABS

13369.8%

ZSQR

0.0%

Profitability & performance

Gross Margin

SABS

0.0%

ZSQR

-24.6%

ROE

SABS

15.2%

ZSQR

-5059.0%

FCF Yield %

ZSQR

-1.4%

SABS

-25.2%

52-Week Performance

SABS

27.4%

ZSQR

-62.8%

Detailed metrics comparison

SABS

SAB Biotherapeutics Inc

ZSQR

Z Squared Inc (Delaware)

Market Cap

SABS$228M

ZSQR$298M

Enterprise Value

SABS$223M

ZSQR$283M

Price

SABS$2.98

ZSQR$5.66

P/E Ratio

SABS20.43x

ZSQRN/A

P/S Ratio

SABS204.97x

ZSQR106.71x

EV/Sales

SABS201.14x

ZSQR101.17x

EV/EBITDA

SABS0.00x

ZSQR0.00x

P/B Ratio

SABS1.26x

ZSQR1.36x

P/FCF Ratio

SABSN/A

ZSQRN/A

EV/FCF

SABS-3.88x

ZSQR-69.99x

PEG Ratio

SABSN/A

ZSQRN/A

Forward P/E (NTM)

SABSN/A

ZSQRN/A

Forward P/S (NTM)

SABSN/A

ZSQRN/A

Revenue (TTM)

SABS$0

ZSQR$3M

Revenue Growth (YoY)

SABSN/A

ZSQR961.0%

Forward Rev Growth

SABS13369.8%

ZSQR0.0%

Gross Margin (TTM)

SABS0.0%

ZSQR-24.6%

Operating Margin (TTM)

SABS0.0%

ZSQR0.0%

EBITDA Margin (TTM)

SABS0.0%

ZSQR-712.5%

Net Margin (TTM)

SABS0.0%

ZSQR-785.1%

FCF Margin (TTM)

SABSN/A

ZSQR-144.6%

Net Income (TTM)

SABS$2M

ZSQR$-22M

FCF (TTM)

SABS$-57M

ZSQR$-4M

EPS (TTM)

SABS$0.00

ZSQR-$0.44

ROE (TTM)

SABS15.2%

ZSQR-5059.0%

ROA (TTM)

SABS12.5%

ZSQR-4757.0%

ROIC (TTM)

SABS14.6%

ZSQR-5038.0%

Cash

SABS$8M

ZSQR$15M

Debt

SABS$3M

ZSQR$0

Net Cash/Debt

SABS$5M

ZSQR$15M

Current Ratio (TTM)

SABS9.22x

ZSQR7.66x

Quick Ratio (TTM)

SABS8.93x

ZSQR7.64x

Debt/Equity (TTM)

SABS0.01x

ZSQR0.02x

Debt/Assets (TTM)

SABS0.0%

ZSQR0.0%

Interest Coverage (TTM)

SABSN/A

ZSQRN/A

Net Debt/EBITDA (TTM)

SABS0.00x

ZSQR0.00x

Beta

SABS0.80

ZSQRN/A

52W Performance

SABS27.4%

ZSQR-62.8%

YTD Performance

SABS-21.0%

ZSQR-62.8%

% from 52W High

SABS-42.1%

ZSQR-69.9%

% from 52W Low

SABS41.9%

ZSQR168.2%

Asset Turnover (TTM)

SABS0.02x

ZSQR0.06x

FCF Yield (TTM)

SABS-25.2%

ZSQR-1.4%

Earnings Yield (TTM)

SABS1.1%

ZSQR-7.4%

Dividend Yield (TTM)

SABSN/A

ZSQRN/A

Rule of 40

SABS0.0

ZSQR816.4

EV/GP/RG

SABSN/A

ZSQRN/A

Ticker research

View SABS research View ZSQR research

Metric	SABS SAB Biotherapeutics Inc	ZSQR Z Squared Inc (Delaware)
Market & Valuation
Market Cap	$228M	$298M
Enterprise Value	$223M	$283M
Price	$2.98	$5.66
P/E Ratio	20.43x	N/A
P/S Ratio	204.97x	106.71x
EV/Sales	201.14x	101.17x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.26x	1.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.88x	-69.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$3M
Revenue Growth (YoY)	N/A	961.0%
Forward Rev Growth	13369.8%	0.0%
Profitability
Gross Margin (TTM)	0.0%	-24.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-712.5%
Net Margin (TTM)	0.0%	-785.1%
FCF Margin (TTM)	N/A	-144.6%
Net Income (TTM)	$2M	$-22M
FCF (TTM)	$-57M	$-4M
EPS (TTM)	$0.00	-$0.44
ROE (TTM)	15.2%	-5059.0%
ROA (TTM)	12.5%	-4757.0%
ROIC (TTM)	14.6%	-5038.0%
Financial Health
Cash	$8M	$15M
Debt	$3M	$0
Net Cash/Debt	$5M	$15M
Current Ratio (TTM)	9.22x	7.66x
Quick Ratio (TTM)	8.93x	7.64x
Debt/Equity (TTM)	0.01x	0.02x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.80	N/A
52W Performance	27.4%	-62.8%
YTD Performance	-21.0%	-62.8%
% from 52W High	-42.1%	-69.9%
% from 52W Low	41.9%	168.2%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.06x
FCF Yield (TTM)	-25.2%	-1.4%
Earnings Yield (TTM)	1.1%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	816.4
EV/GP/RG	N/A	N/A
Ticker research	View SABS research	View ZSQR research